@Puddyeater2 I think Bactisure Wound Lavage has been approved and is available in the US, Canada, Chile, New Zealand, South Africa and Australia, BlastX Antimicrobial Wound Gel is an approved product (not exactly sure where, but I think it is in the US) and comes back under NXS' control from second quarter 2021 (see NXS' investor presentation 22 Feb 2021). Re Xperience No Rinse Anti Microbial Solution this one hasn't been approved at the moment by the US FDA. DYOR
Ann: Investor Presentation, page-13
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $84.59M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 27.5¢ | $25.44K | 88.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 12840 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NXS (ASX) Chart |